Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Enzyme-Linked Immunosorbent Assay

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.

Bioequivalence Data: Statistical Interpretation

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A self-assembled protein β-helix as a self-contained biofunctional motif.

Nature communications·2025

Same author

An aperiodic chiral tiling by topological molecular self-assembly.

Nature communications·2025

Same author

A Nonlinear Peptide Topology for Synthetic Virions.

ACS nano·2024

Same author

Bayesian uncertainty evaluation applied to the tilted-wave interferometer.

Optics express·2024

Same author

Switching the on-surface orientation of oxygen-functionalized helicene.

Chirality·2024

Same author

Hyperspectral Mapping of Human Primary and Stem Cells at Cell-Matrix Interfaces.

ACS applied materials & interfaces·2024

Search research articles

Related Experiment Video

Updated: May 31, 2026

Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test

Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test

Published on: July 14, 2023

Bayesian analysis of an international ELISA comparability study.

Katy Klauenberg¹, Bernd Ebert, Jan Voigt

¹Physikalisch-Technische Bundesanstalt (PTB), Abbestr. 2-12, 10587 Berlin, Germany. Katy.Klauenberg@Ptb.de

Clinical Chemistry and Laboratory Medicine

|July 6, 2011

Summary

Bayesian inference reveals larger uncertainties in enzyme-linked immunosorbent assays (ELISA) measurements, improving laboratory consistency. Reliable uncertainty estimates are crucial for accurate clinical decisions and diagnostics.

More Related Videos

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Published on: April 21, 2019

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

Related Experiment Videos

Last Updated: May 31, 2026

Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test

Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test

Published on: July 14, 2023

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Published on: April 21, 2019

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

Area of Science:

Biochemistry
Immunology
Statistical Modeling

Background:

Immunoassays, including enzyme-linked immunosorbent assays (ELISA), quantify substances using antibody-antigen binding.
Measurement uncertainty in immunoassays can impact diagnoses and clinical decisions.
An international study assessed uncertainty sources in fluorescent ELISA for protein cytokine concentration.

Purpose of the Study:

To reanalyze international comparability study data using Bayesian inference.
To provide a statistically coherent method for estimating ELISA concentrations and uncertainties.
To demonstrate the importance of reliable uncertainties in immunoassay measurements.

Main Methods:

Reanalysis of existing international comparability study data.
Application of Bayesian inference for estimating ELISA concentrations.
Calculation of associated measurement uncertainties.

Main Results:

Bayesian uncertainties for ELISAs and laboratory estimates are larger than previously reported.
Estimated average concentrations differ from participant estimates, altering study conclusions.
Improved inter- and intra-laboratory consistency with reduced repeatability issues.

Conclusions:

Credible intervals from Bayesian analysis offer superior decision-making compared to point estimates.
Accurate uncertainty quantification is vital for immunoassay applications beyond metrology.
A general Bayesian method for deriving ELISA concentration estimates and uncertainties is presented and validated.